Louis B. Rice, MD
Acknowledgments: The author thanks Martin Blaser, MD, and Steve Czinn, MD, for their helpful advice and perspectives on H. pylori infection.
Potential Financial Conflicts of Interest:Consultancies: Wyeth Pharmaceuticals, Elan Pharmaceuticals, InterMune, Cubist, Pharmacia, Exponential Therapies, Basilea, Bristol-Myers Squibb, Merck and Co., Theravance, Genome Therapeutics, Shire Pharmaceuticals; Honoraria: Wyeth Pharmaceuticals, Elan Pharmaceuticals, Merck and Co.; Grants received: Wyeth Pharmaceuticals, Elan Pharmaceuticals, InterMune.
Requests for Single Reprints: Louis B. Rice, MD, Medical Service 111(W), Louis Stokes Cleveland Veterans Affairs Medical Center, 10701 East Boulevard, Cleveland, OH 44106; e-mail, email@example.com.
Rice LB. Collateral Damage. Ann Intern Med. 2003;139:523–524. doi: 10.7326/0003-4819-139-6-200309160-00017
Download citation file:
Published: Ann Intern Med. 2003;139(6):523-524.
Gastroenterology/Hepatology, H. Pylori, Infectious Disease, Peptic Disease.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use